Alvotech And Fuji Further Expand Biosimilars Partnership
Japanese Commercialization Alliance Now Covers Six Alvotech Candidates
Alvotech and Fuji Pharma have extended their strategic alliance for the commercialization of Alvotech biosimilars in Japan, adding a further early-stage candidate to the list of products covered by the deal that now encompasses six biosimilars.
